FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085276629> ?p ?o ?g. }

• W2085276629 endingPage "e84976" @default.
• W2085276629 startingPage "e84976" @default.
• W2085276629 abstract "Background Artemisinin combination therapy (ACT) is recommended for the treatment of multidrug resistant malaria in the second and third trimesters of pregnancy, but the experience with ACTs is limited. We review the exposure of pregnant women to the combination dihydroartemisinin-piperaquine over a 6 year period. Methods From April 2004–June 2009, a prospective hospital-based surveillance screened all pregnant women for malaria and documented maternal and neonatal outcomes. Results Data were available on 6519 pregnant women admitted to hospital; 332 (5.1%) women presented in the first trimester, 324 (5.0%) in the second, 5843 (89.6%) in the third, and in 20 women the trimester was undocumented. Peripheral parasitaemia was confirmed in 1682 women, of whom 106 (6.3%) had severe malaria. Of the 1217 women admitted with malaria in the second and third trimesters without an impending adverse outcome, those treated with DHP were more likely to be discharged with an ongoing pregnancy compared to those treated with a non-ACT regimen (Odds Ratio OR = 2.48 [1.26–4.86]); p = 0.006. However in the first trimester 63% (5/8) of women treated with oral DHP miscarried compared to 2.6% (1/38) of those receiving oral quinine; p<0.001. Of the 847 women admitted for delivery those reporting a history of malaria during their pregnancy who had been treated with quinine-based regimens rather than DHP had a higher risk of malaria at delivery (adjusted OR = 1.56 (95%CI 0.97–2.5), p = 0.068) and perinatal mortality (adjusted OR = 3.17 [95%CI: 1.17–8.60]; p = 0.023). Conclusions In the second and third trimesters of pregnancy, a three day course of DHP simplified antimalarial treatment and had significant benefits over quinine-based regimens in reducing recurrent malaria and poor fetal outcome. These data provide reassuring evidence for the rational design of prospective randomized clinical trials and pharmacokinetic studies." @default.
• W2085276629 created "2016-06-24" @default.
• W2085276629 creator A5006917424 @default.
• W2085276629 creator A5013450022 @default.
• W2085276629 creator A5018693062 @default.
• W2085276629 creator A5019034894 @default.
• W2085276629 creator A5020224633 @default.
• W2085276629 creator A5032095213 @default.
• W2085276629 creator A5069443424 @default.
• W2085276629 creator A5072560021 @default.
• W2085276629 date "2014-01-17" @default.
• W2085276629 modified "2023-10-18" @default.
• W2085276629 title "Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy" @default.
• W2085276629 cites W1483203554 @default.
• W2085276629 cites W1969763842 @default.
• W2085276629 cites W2003123290 @default.
• W2085276629 cites W2023941860 @default.
• W2085276629 cites W2026627865 @default.
• W2085276629 cites W2027637662 @default.
• W2085276629 cites W2031937210 @default.
• W2085276629 cites W2061006318 @default.
• W2085276629 cites W2097515131 @default.
• W2085276629 cites W2105104428 @default.
• W2085276629 cites W2119532990 @default.
• W2085276629 cites W2129000670 @default.
• W2085276629 cites W2141478039 @default.
• W2085276629 cites W2143758677 @default.
• W2085276629 cites W2145726869 @default.
• W2085276629 cites W2146252512 @default.
• W2085276629 cites W2150801421 @default.
• W2085276629 cites W2151019491 @default.
• W2085276629 cites W2154959709 @default.
• W2085276629 cites W2156469502 @default.
• W2085276629 cites W2160756895 @default.
• W2085276629 cites W2166357496 @default.
• W2085276629 cites W2310319955 @default.
• W2085276629 doi "https://doi.org/10.1371/journal.pone.0084976" @default.
• W2085276629 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3894943" @default.
• W2085276629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24465458" @default.
• W2085276629 hasPublicationYear "2014" @default.
• W2085276629 type Work @default.
• W2085276629 sameAs 2085276629 @default.
• W2085276629 citedByCount "37" @default.
• W2085276629 countsByYear W20852766292014 @default.
• W2085276629 countsByYear W20852766292015 @default.
• W2085276629 countsByYear W20852766292016 @default.
• W2085276629 countsByYear W20852766292017 @default.
• W2085276629 countsByYear W20852766292018 @default.
• W2085276629 countsByYear W20852766292019 @default.
• W2085276629 countsByYear W20852766292020 @default.
• W2085276629 countsByYear W20852766292021 @default.
• W2085276629 countsByYear W20852766292023 @default.
• W2085276629 crossrefType "journal-article" @default.
• W2085276629 hasAuthorship W2085276629A5006917424 @default.
• W2085276629 hasAuthorship W2085276629A5013450022 @default.
• W2085276629 hasAuthorship W2085276629A5018693062 @default.
• W2085276629 hasAuthorship W2085276629A5019034894 @default.
• W2085276629 hasAuthorship W2085276629A5020224633 @default.
• W2085276629 hasAuthorship W2085276629A5032095213 @default.
• W2085276629 hasAuthorship W2085276629A5069443424 @default.
• W2085276629 hasAuthorship W2085276629A5072560021 @default.
• W2085276629 hasBestOaLocation W20852766291 @default.
• W2085276629 hasConcept C126322002 @default.
• W2085276629 hasConcept C131872663 @default.
• W2085276629 hasConcept C156957248 @default.
• W2085276629 hasConcept C187212893 @default.
• W2085276629 hasConcept C203014093 @default.
• W2085276629 hasConcept C2776120307 @default.
• W2085276629 hasConcept C2777616469 @default.
• W2085276629 hasConcept C2777617192 @default.
• W2085276629 hasConcept C2778048844 @default.
• W2085276629 hasConcept C2778371730 @default.
• W2085276629 hasConcept C2779234561 @default.
• W2085276629 hasConcept C2779997623 @default.
• W2085276629 hasConcept C2781160685 @default.
• W2085276629 hasConcept C2781413609 @default.
• W2085276629 hasConcept C54355233 @default.
• W2085276629 hasConcept C71924100 @default.
• W2085276629 hasConcept C86803240 @default.
• W2085276629 hasConceptScore W2085276629C126322002 @default.
• W2085276629 hasConceptScore W2085276629C131872663 @default.
• W2085276629 hasConceptScore W2085276629C156957248 @default.
• W2085276629 hasConceptScore W2085276629C187212893 @default.
• W2085276629 hasConceptScore W2085276629C203014093 @default.
• W2085276629 hasConceptScore W2085276629C2776120307 @default.
• W2085276629 hasConceptScore W2085276629C2777616469 @default.
• W2085276629 hasConceptScore W2085276629C2777617192 @default.
• W2085276629 hasConceptScore W2085276629C2778048844 @default.
• W2085276629 hasConceptScore W2085276629C2778371730 @default.
• W2085276629 hasConceptScore W2085276629C2779234561 @default.
• W2085276629 hasConceptScore W2085276629C2779997623 @default.
• W2085276629 hasConceptScore W2085276629C2781160685 @default.
• W2085276629 hasConceptScore W2085276629C2781413609 @default.
• W2085276629 hasConceptScore W2085276629C54355233 @default.
• W2085276629 hasConceptScore W2085276629C71924100 @default.
• W2085276629 hasConceptScore W2085276629C86803240 @default.
• W2085276629 hasIssue "1" @default.
• W2085276629 hasLocation W20852766291 @default.

• next